How much funding has AskBio raised?

AskBio has raised $225.0M in total funding, most recently a Growth Equity round.

Who are AskBio's investors?

AskBio's investors include Leaps by Bayer, TPG (Growth/Rise), Vida Ventures.

Where is AskBio headquartered?

AskBio is headquartered in Research Triangle Park, North Carolina, United States.

What industry is AskBio in?

AskBio operates in Biotech, Healthcare.

AskBio

Acquired

AAV Gene Therapy Technology & Therapeutics

Research Triangle Park, United States · Founded 2011 · $225.0M raised

Biotech

Healthcare

Headquarters: Research Triangle Park, North Carolina
Employees: 201–500
Founded: 2011
Business Model: B2B

Website: askbio.com
Total Funding: $225.0M
Last Round: $225.0M Growth EquityJan 2019
Rounds: 1

About

AskBio (Asklepios BioPharmaceutical) is a fully integrated gene therapy company and wholly owned subsidiary of Bayer AG, specializing in AAV-based therapies for genetic and neurological disorders. Its pipeline includes investigational treatments for Parkinson's disease, Pompe disease, and heart failure. AskBio's proprietary Pro10 manufacturing platform and neDNA technology support clinical-stage and commercial-scale gene therapy production.

Summary

AskBio is a Biotech company based in Research Triangle Park, United States, founded in 2011. It has raised $225.0M in total across 1 round, most recently a $225.0M Growth Equity round in Jan 2019. Investors include Leaps by Bayer, TPG (Growth/Rise) and Vida Ventures.

LinkedIn X (Twitter)